ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "ANCA"

  • Abstract Number: 0526 • ACR Convergence 2022

    Characteristics and Outcomes of Participants with and Without Diffuse Alveolar Hemorrhage in the Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis (PEXIVAS) Trial

    Lynn Fussner1, Luis Felipe Flores-Suarez2, Rodrigo Cartin-Ceba3, Ulrich Specks3, P. Gerard Cox4, David Jayne5, Peter Merkel6 and Michael Walsh4, 1The Ohio State University, Columbus, OH, 2Instituto Nacional de Enfermedades Respiratorias, Ciudad de México, Mexico, 3Mayo Clinic, Rochester, MN, 4McMaster University, Hamilton, ON, Canada, 5University of Cambridge, Cambridge, United Kingdom, 6University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Diffuse alveolar hemorrhage (DAH) is a potentially life-threatening manifestation of ANCA-associated vasculitis (AAV). Studies describing patients with DAH in AAV have typically been small…
  • Abstract Number: 1072 • ACR Convergence 2022

    Efficacy and Safety Assessment of a Rituximab Biosimilar in Patients with Granulomatosis with Polyangiitis (GPA)

    Adil Vural1, Komal Mushtaq1, Chao Zhang1, Mahmoud Alwakeel1, Vickie Sayles1, Kristine Duly2, Carol Langford1 and Rula Hajj-Ali3, 1Cleveland Clinic, Cleveland, OH, 2Cleveland Clinic, Fairview Park, OH, 3Cleveland Clinic, Hunting Valley, OH

    Background/Purpose: A biosimilar is a medication that is highly similar to a biologic agent that is already approved by a regulatory organization. Considering the share…
  • Abstract Number: 1073 • ACR Convergence 2022

    Analysis of Clinical Outcomes in ANCA-associated Vasculitis Treated with Rituximab: Eighty Years a Single Center Experience in Japan

    Soko Kawashima1, Mitsumasa Kishimoto2, Yoshinori Komagata3 and Shinya kaname4, 1Kyorin University, Mitaka Tokyo, Japan, 2Kyorin University School of Medicine, Yokohama, Japan, 3Kyorin University School of Medicine, Tokyo, Japan, 4Kyorin University, Tokyo, Japan

    Background/Purpose: Contrary to many Western countries, MPO-ANCA-associated vasculitis (MPO-AAV) is dominant in Japan. The therapeutic response to rituximab (RTX) may differ. Therefore, we conducted a…
  • Abstract Number: 1075 • ACR Convergence 2022

    Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis and a Vasculitic Phenotype

    Benjamin Terrier1, David Jayne2, Bernhard Hellmich3, Jane Bentley4, Jonathan Steinfeld5, Steven Yancey6, Namhee Kwon7, Praveen Akuthota8, Paneez Khoury9, Lee Baylis10 and Michael Wechsler11, 1National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France, 2University of Cambridge, Cambridge, United Kingdom, 3Klinik für Innere Medizin, Rheumatologie & Immunologie, Medius Kliniken, Universität Tübingen, Plochingen, Germany, 4Clinical Statistics, GlaxoSmithKline, Brentford, United Kingdom, 5Clinical Sciences, Respiratory, GSK (affiliation at time of research), Philadelphia, PA, 6Respiratory Therapeutic Area, GSK (affiliation at the time of research), Research Triangle Park, NC, 7Clinical Sciences, Respiratory, GSK, Brentford, United Kingdom, 8Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of California, San Diego, CA, 9Human Eosinophil Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 10Global Medical Affairs, GlaxoSmithKline, Durham, NC, 11Department of Medicine, National Jewish Health, Denver, CO

    Background/Purpose: Patients with eosinophilic granulomatosis with polyangiitis (EGPA) can have vasculitic or eosinophilic phenotypes. The MIRRA study demonstrated that patients with EGPA spent more time…
  • Abstract Number: 1082 • ACR Convergence 2022

    Outcomes of Methotrexate as an Initial Induction and Maintenance Regimen for Localized Granulomatosis with Polyangiitis: A Retrospective Review

    Pratyusha Banik1, Marcia Friedman2, Daniela Ghetie3, Dongseok Choi4 and Margaret Brophy1, 1Oregon Health & Science University, Portland, OR, 2Oregon Health and Science University, Division of Arthritis and Rheumatic Diseases, Portland, OR, 3Oregon Health & Science University, Division of Arthritis and Rheumatic Diseases, Lake Oswego, OR, 4OHSU-PSU School of Public Health, Portland, OR

    Background/Purpose: While there is established data regarding the induction and maintenance treatment of systemic or organ threatening granulomatosis with polyangiitis (GPA), there is limited data…
  • Abstract Number: 1085 • ACR Convergence 2022

    Safety of Plasmapheresis as an Adjuvant Therapy in Severe Pediatric Anti-neutrophil Cytoplasmic Antibody Associated Vasculitis: A Single Center Cohort

    Sharanya Joginpalli1, Alvaro Orjuela2, Marietta De Guzman3 and Emily Frierson2, 1Baylor College of Medicine- Texas Children's Hospital, Houston, TX, 2Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 3Baylor College of Medicine/ Texas Children's Hospital, Houston, TX

    Background/Purpose: Therapeutic plasma exchange (TPE) is used in anti-neutrophil cytoplasmic antibody associated vasculitis (AAV) as adjunct treatment for severe disease. There is paucity of data…
  • Abstract Number: 1086 • ACR Convergence 2022

    Characteristics and Outcomes of Patients with ANCA Associated Vasculitis Treated with Plasma Exchange: An Analysis of the National Inpatient Sample Database

    Vinit Gilvaz1, Akil Sherif2, Sonu Abraham3, Anu Saji2 and Anthony Reginato4, 1Brown University, East Providence, RI, 2Saint Vincent Hospital, Worcester, MA, 3Lahey Medical Center, Burlington, MA, 4Brown University, Providence, RI

    Background/Purpose: Plasma exchange (PLEX) has been used in the management of patients with severe anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) for decades. The most recent…
  • Abstract Number: 1089 • ACR Convergence 2022

    Prognostic Value of Proteinuria Monitoring in Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis

    Yeo jin lee1, Soo Min Ahn2, Ji Seon Oh3, Yong Gil Kim2, Chang Keun Lee2, Bin Yoo2 and Seokchan Hong2, 1Asan medical center, Seoul, Republic of Korea, 2Department of Rheumatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea, Seoul, Republic of Korea, 3Department of Information Medicine, Big Data Research Center, Asan Medical Center, Seoul, Republic of Korea

    Background/Purpose: Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) is an autoimmune disease that can involve various organs systematically. Kidney involvement, one of the major manifestations of AAV,…
  • Abstract Number: 0436 • ACR Convergence 2022

    Clinical Characteristics and Outcome of ANCA-Associated Vasculitides Induced by Anti-Thyroid Drugs: A Multicenter Retrospective Cohort Study

    Julien Culerrier1, Yann Nguyen2, Omer Karadag3, Sule Yasar Bilge4, Tuba DEMIRCI YILDIRIM5, Tahir Saygin Öğüt6, Veli Yazisiz6, Cemal Bes7, Ayse Cefle8, Oznur Sadioglu Cagdas9, Ayten Yazici8, Andreas Kronbichler10, David Jayne10, Alexis Regent11, Vitor Teixeira12, Sylvain Marchand-Adam13, PIerre Duffau14, Saskia Oro15, Baptiste Andre16, Luminita Luca17, Sarah Lechtman18, Achille Aouba19, Celine Lebas20, Amélie Servettaz21, Amandine Dernoncourt22, Marc Ruivard23, Anne-Marie Milesi24, Vincent Poindron25, Patrick Jego26, Roberto Padoan27, Paolo Delvino28, Frédéric Vandergheynst29, Christian Pagnoux30, Elaine Yacyshyn31, Peter Lamprecht32, Oliver Flossmann33, Xavier Puéchal11 and Benjamin Terrier11, 1Université Paris Cité, Paris, France, Paris, France, 2AP-HP.Centre Universit Paris Cit Hôpital Cochin, Montmorency, France, 3Hacettepe University, Ankara, Turkey, 4Eskişehir Osmangazi Üniversity, Eskisehir, Turkey, 5Dokuz Eylul University, İzmir, Turkey, 6Akdeniz University, Antalya, Turkey, 7Bahçeşehi University, Istanbul, Turkey, 8Kocaeli University School of Medicine Division of Rheumatology, Kocaeli, Turkey, 9Kocaeli University, Kocaeli, Turkey, 10University of Cambridge, Cambridge, United Kingdom, 11National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France, 12Hospital de Faro, CHUA, Lisbon, Portugal, 13Tours University Hospital, Tours, France, 14CHU Bordeaux, Bordeaux, France, 15Assistance Publique - Hôpitaux de Paris., Paris, France, 16Hôpital de la Timone, Marseille, Marseille, France, 17CHU de Poitiers, Poitiers, France, 18CHU Nice, Nice, France, 19Department of Internal Medicine, UR4650 PSIR, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, France, 20CHRU Lille, Lille, France, 21CHU Reims, Reims, France, 22CHU Amiens - Picardie, Amiens, France, 23Clermont Ferrand University Hospital, Clermont-Ferrand, France, 24Centre hospitalier de Vichy, Vichy, France, 25Immunologie clinique et médecine interne, Hôpitaux universitaires de Strasbourg, Strasbourg, France, 26CHU Rennes, Paris, France, 27University of Padova, Padova, Italy, 28Università di Pavia, Vercelli, Italy, 29Professeur de Médecine Interne et Sémiologie médicale, Directeur de la Clinique de Médecine Interne Générale, Université Libre de Bruxelles, Bruxelles, France, 30Division of Rheumatology, Mount Sinai Hospital, Toronto, ON, Canada, 31University of Alberta, Edmonton, AB, Canada, 32Department of Rheumatology University of Lübeck Ratzeburger Allee, Lübeck, Germany, 33Royal Berkshire Hospital, Reading, United Kingdom

    Background/Purpose: ANCA-associated vasculitides (AAV) induced by anti-thyroid drugs (ATD) is a well-known entity. However, characteristics, requirement for immunosuppressive agents and the risk of relapse remain…
  • Abstract Number: 1573 • ACR Convergence 2022

    Von – Willebrand Factor, a Possible Marker for Disease Activity in Vasculitis

    Jomana mazareeb1, shiri keret1, Abid Awisat1, Itzhak Rosner2, Michel Rozenbaum3, Lisa Kaly1, Gleb Slobodin1 and Doron Rimar1, 1Bnai Zion Medical Center, Haifa, Israel, 2Bnai Zion Medical Center/Technion, Haifa, Israel, 3Bnei Zion Medical Center, Hertzeliya, Israel

    Background/Purpose: Vasculitis is an inflammation of blood vessels. While in many cases markers of inflammation as c- reactive protein (CRP) or erythrocytes sedimentation rate (ESR)…
  • Abstract Number: 0438 • ACR Convergence 2022

    Characterization of Interstitial Lung Disease in the Presence of Antineutrophil Cytoplasmic Antibodies

    Khai-Tuan Andrew Bui1, Rachel Richard2, Ariane Drouin3, Nader Toban1, Marianne Levesque4, Rosalie-Selene Meunier5, Carolyn Ross6 and Jean-Paul Makhzoum3, 1Department of Medicine, Hopital du Sacre-Coeur de Montreal, University of Montreal, Montréal, QC, Canada, 2Department of Medicine, Hopital du Sacre-Coeur de Montreal, University of Montreal, Laval, QC, Canada, 3Vasculitis Clinic, Canadian Network for Research on Vasculitides (CanVasc), Department of Medicine, Hopital du Sacre-Coeur de Montreal, University of Montreal, Montréal, QC, Canada, 4Division of Respirology, Department of Medicine, Hopital du Sacre-Coeur de Montreal, University of Montreal, Montréal, QC, Canada, 5Hopital Sacre-Coeur, Universite de Montreal, Montréal, QC, Canada, 6University of Montreal, Montréal, QC, Canada

    Background/Purpose: Various pulmonary manifestations may occur in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). ANCA-related interstitial lung disease (ILD) has recently been described in…
  • Abstract Number: 1688 • ACR Convergence 2022

    Biomechanical Phenotype of Circulating Neutrophils Is Altered in ANCA Associated Vasculitis

    Noelle Pisacano1, Stephen P. McAdoo1, Jochen Guck2, Charles D. Pusey1, Edwin R. Chilvers1, Andrew S. Cowburn1, Katharine M. Lodge1 and Maria F. Prendecki1, 1Imperial College London, London, United Kingdom, 2Max Planck Institute, Erlangen, Germany

    Background/Purpose: Real Time-Deformability Cytometry (RT-DC) is a novel technique able to identify morpho-rheological characteristics of individual cells such as size, deformability, and elasticity using only…
  • Abstract Number: 0439 • ACR Convergence 2022

    Clinical Characteristics of Patients with ANCA-Associated Vasculitis with and Without Alpha-1 Antitrypsin Deficiency Alleles

    Lynn Fussner1, David Cuthbertson2, Peter Grayson3, David Jayne4, Carol McAlear5, Michael Walsh6, Katherine Siminovitch7, Ulrich Specks8 and Peter Merkel9, 1The Ohio State University, Columbus, OH, 2University of South Florida, Tampa, FL, 3National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 4University of Cambridge, Cambridge, United Kingdom, 5Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA, 6McMaster University, Hamilton, ON, Canada, 7University of Toronto, Toronto, ON, Canada, 8Mayo Clinic, Rochester, MN, 9University of Pennsylvania, Philadelphia, PA

    Background/Purpose: There are multiple reasons to suspect that alpha-1 antitrypsin (A1AT) genotype impacts disease characteristics in ANCA-associated vasculitis (AAV). A1AT serves as the predominant endogenous…
  • Abstract Number: 1928 • ACR Convergence 2022

    Idiopathic Pulmonary Capillaritis Within the Spectrum of Pediatric Diffuse Alveolar Hemorrhage

    Angela Chun1, Tiphanie vogel1, Andrea Ramirez1, Marietta De Guzman2, Eyal Muscal1 and Manuel Silva-Carmona3, 1Baylor College of Medicine, Houston, TX, 2Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, 3Baylor College of Medicine, Texas Children's Hospital, Houston, TX

    Background/Purpose: Diffuse alveolar hemorrhage (DAH) is a life-threatening syndrome with bleeding from the pulmonary microvasculature. It is classified as pulmonary capillaritis if histology shows neutrophilic…
  • Abstract Number: 0418 • ACR Convergence 2021

    Longitudinal Patterns of Renal Function in ANCA-Associated Vasculitis

    Jennifer Hanberg1, Xiaoqing Fu1, Claire Cook2, John Stone3, Hyon K. Choi4 and Zachary Wallace5, 1Massachusetts General Hospital, Boston, MA, 2Division of Rheumatology, Allergy, and Immunology, Mass General Hospital, Boston, MA, 3Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA, 4Massachusetts General Hospital, Lexington, MA, 5Massachusetts General Hospital, Newton, MA

    Background/Purpose: Renal involvement is common in ANCA-associated vasculitis (AAV). Prior analyses show that end stage renal disease (ESRD) in AAV may be multifactorial. Little is…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 20
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology